BioLumic unlocks the natural genetic potential of seeds and seedlings with specialized light treatments, data science, and technology.
BioLumic has raised $8.3M in total funding. The most recent round was Series B. The last funding was announced in April 2025.
BioLumic's investors include Icehouse Ventures, OurCrowd, Azolla Ventures, Virtu Financial, iSelect Fund.
BioLumic is headquartered in Palmerston North, New Zealand.
BioLumic unlocks the natural genetic potential of seeds and seedlings with specialized light treatments, data science, and technology.
BioLumic is at the Series B stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"BioLumic — Funding & Investors." VCBacked, April 22, 2025, https://www.vcbacked.co/company/biolumic. Accessed July 20, 2026.
VCBacked. (2025). BioLumic — Funding & Investors. Retrieved July 20, 2026, from https://www.vcbacked.co/company/biolumic
{{cite web |title=BioLumic — Funding & Investors |url=https://www.vcbacked.co/company/biolumic |website=VCBacked |access-date=July 20, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated